Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression, the perimenopause, and estrogen therapy.

Peter J Schmidt1

  • 1Behavioral Endocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bldg. 10-CRC, Rm. 6-5340, 10 Center Dr., MSC 1276, Bethesda, MD 20892-1276, USA. peterschmidt@mail.nih.gov

Annals of the New York Academy of Sciences
|July 19, 2005
PubMed
Summary

Perimenopause may trigger depression in some women due to reproductive changes. Estradiol shows short-term antidepressant effects in depressed perimenopausal women, suggesting a role for ovarian hormones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Based Approach for Automated Gonad Volume Quantification Using Magnetic Resonance Imaging in Healthy Adolescents Across Puberty.

Diagnostics (Basel, Switzerland)·2026
Same author

Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.

The American journal of psychiatry·2025
Same author

Postmortem tissue biomarkers of menopausal transition.

Molecular psychiatry·2025
Same author

Differential sensitivity: not more or less.

The British journal of psychiatry : the journal of mental science·2025
Same author

Cortisol and ACTH response to Dex/CRH testing and 24-hour urine free cortisol levels in women with and without premenstrual dysphoric disorder.

Psychoneuroendocrinology·2024
Same author

Adamantane-Type Nitridophosphate Phosphors AE<sub>x</sub>Li<sub>10-2x</sub>P<sub>4</sub>N<sub>10</sub> : Eu2<sup>+</sup> via Medium-Pressure Ion-Exchange Reactions.

Angewandte Chemie (International ed. in English)·2024

Area of Science:

  • Reproductive endocrinology
  • Neuroscience
  • Psychiatry

Background:

  • Perimenopause is characterized by significant reproductive function variability.
  • Some women experience increased susceptibility to depression during this transition.
  • Hormonal fluctuations, including decreased estradiol, are noted in late perimenopause.

Purpose of the Study:

  • To examine the link between perimenopausal reproductive events and the onset of depression in women.
  • To investigate the potential causal role of ovarian hormone variability in depression development during perimenopause.

Main Methods:

  • Review of epidemiologic studies on depression during the menopausal transition.
  • Analysis of recent longitudinal studies on perimenopause and depression onset.

Related Experiment Videos

  • Evaluation of randomized controlled trials on estradiol's antidepressant efficacy.

    • Main Results:

    • Most women do not develop depression during perimenopause.
    • Longitudinal data suggest perimenopause-related events contribute to depression in some individuals.
    • Estradiol demonstrated short-term antidepressant efficacy in depressed perimenopausal women.

    Conclusions:

    • Depression is not a universal outcome of the menopausal transition.
    • Age-related changes in ovarian estrogen production may influence central nervous system function, predisposing some women to depression.
    • Reproductive events during perimenopause are implicated in the onset of depression for a subset of women.